Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06502743
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-06-23
Brief Title:
First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab Followed by Maintenance Pembrolizumab With or Without Nesuparib in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient pMMR Endometrial Cancer
Sponsor:
Organization:
None